CALA - Calithera Biosciences' (CALA) CEO Susan Molineaux on Q3 2020 Results - Earnings Call Transcript

Calithera Biosciences, Inc. (CALA) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Jennifer McNealey – Investor Relations Susan Molineaux – Founder, President and Chief Executive Officer Keith Orford – Chief Medical Officer Stephanie Wong – Senior Vice President-Finance Conference Call Participants David Ruch – SVB Leerink Yu He – H.C. Wainwright Matt Phipps – William Blair James Shin – Citi Presentation Operator Thank you for standing by. And welcome to the Calithera Biosciences Q3 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] I will now turn the call over to your speaker for today, Ms. Jennifer McNealey. Please begin. Jennifer McNealey Thank you, Jenny. Good afternoon, everyone. Welcome to our third quarter 2020 conference call. Joining me today are Susan Molineaux, our Founder, President and CEO; Keith Orford,

For further details see:

Calithera Biosciences' (CALA) CEO Susan Molineaux on Q3 2020 Results - Earnings Call Transcript